Concepedia

Melissa L. Geddie

ML

13

Publications

1.4K

Citations

12

H-Index

2003

Active since

Affiliations

Merrimack Pharmaceuticals (United States)(Current)

Emory University

Howard Hughes Medical Institute

Whitehead Institute for Biomedical Research

Massachusetts Institute of Technology

Melissa L. Geddie is an author at Merrimack Pharmaceuticals (United States) specializing in medicine, molecular biology, and protein engineering.

Top concepts

MedicineMolecular BiologyEngineeringProtein EngineeringPharmacologyNatural SciencesAntibody EngineeringBiomolecular EngineeringImmunologyNanomedicine

Publications per year

2003–2019

13

Publications

13

α-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity

Aaron D. Gitler, Alessandra Chesi, Melissa L. Geddie et al. · Nature Genetics · 2009 · 533 citations · Full text

Neurodegenerative Diseases, Molecular Neuroscience, Biochemistry +9

Bridging high-throughput genetic and transcriptional data reveals cellular responses to alpha-synuclein toxicity

Esti Yeger‐Lotem, Laura Riva, Linhui Julie Su et al. · Nature Genetics · 2009 · 292 citations · Full text

Knockout Mouse, Neurodegenerative Diseases, Functional Genomics +9

Polyamine pathway contributes to the pathogenesis of Parkinson disease

Nicole Lewandowski, Shulin Ju, Miguel Verbitsky et al. · Proceedings of the National Academy of Sciences · 2010 · 156 citations · Full text

Neurogenomics, Molecular Biology, Neurochemical Biomarkers +19

A novel screening method to assess developability of antibody-like molecules

Neeraj Kohli, Melissa L. Geddie, Maja Razlog et al. · mAbs · 2015 · 76 citations · Full text

Immunocytochemical Technique, Engineering, Immunology +20

Rapid Evolution of β-Glucuronidase Specificity by Saturation Mutagenesis of an Active Site Loop

Melissa L. Geddie, Ichiro Matsumura · Journal of Biological Chemistry · 2004 · 69 citations · Full text

Rows per page

1–5 of 13